{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:03:46Z","timestamp":1779984226655,"version":"3.53.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100000026","name":"Institute of Aging","doi-asserted-by":"publisher","award":["MOP-82798"],"award-info":[{"award-number":["MOP-82798"]}],"id":[{"id":"10.13039\/501100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000026","name":"Institute of Aging","doi-asserted-by":"publisher","award":["RNS- 117795"],"award-info":[{"award-number":["RNS- 117795"]}],"id":[{"id":"10.13039\/501100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000026","name":"Institute of Aging","doi-asserted-by":"publisher","award":["MOP-119343"],"award-info":[{"award-number":["MOP-119343"]}],"id":[{"id":"10.13039\/501100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000026","name":"Institute of Aging","doi-asserted-by":"publisher","award":["PJT \u2013 153319"],"award-info":[{"award-number":["PJT \u2013 153319"]}],"id":[{"id":"10.13039\/501100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007670","name":"Dalhousie Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007670","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Foundation for Innovation","award":["Grant No. 37854"],"award-info":[{"award-number":["Grant No. 37854"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"DOI":"10.1007\/s11307-026-02107-7","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:17:33Z","timestamp":1779981453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Imaging of Butyrylcholinesterase Associated with Amyloid-\u03b2 Plaques Distinguishes 5XFAD from Wild-Type Mice: A Proof-of-Concept"],"prefix":"10.1007","author":[{"given":"G. Andrew","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew R.","family":"DeBay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoun Bou","family":"Laouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Pottie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-7761","authenticated-orcid":false,"given":"Sultan","family":"Darvesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"3","key":"2107_CR1","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00015.2020","volume":"101","author":"C Ferrari","year":"2021","unstructured":"Ferrari C, Sorbi S (2021) The complexity of Alzheimer\u2019s disease: an evolving puzzle. Physiol Rev 101(3):1047\u20131081. https:\/\/doi.org\/10.1152\/physrev.00015.2020","journal-title":"Physiol Rev"},{"issue":"8","key":"2107_CR2","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/s41591-024-02988-7","volume":"30","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews SJ, Beach TG et al (2024) Revised criteria for the diagnosis and staging of Alzheimer\u2019s disease. Nat Med 30(8):2121\u20132124. https:\/\/doi.org\/10.1038\/s41591-024-02988-7","journal-title":"Nat Med"},{"issue":"11","key":"2107_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s43587-024-00731-y","volume":"4","author":"J Therriault","year":"2024","unstructured":"Therriault J, Janelidze S, Benedet AL et al (2024) Diagnosis of Alzheimer\u2019s disease using plasma biomarkers adjusted to clinical probability. Nat Aging 4(11):1529\u20131537. https:\/\/doi.org\/10.1038\/s43587-024-00731-y","journal-title":"Nat Aging"},{"issue":"10452","key":"2107_CR4","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston G, Huntley J, Liu KY et al (2024) Dementia prevention, intervention, and care: 2024 report of the Lancet Standing Commission. Lancet 404(10452):572\u2013628. https:\/\/doi.org\/10.1016\/S0140-6736(24)01296-0","journal-title":"Lancet"},{"issue":"8000","key":"2107_CR5","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/s0140-6736(76)91936-x","volume":"2","author":"P Davies","year":"1976","unstructured":"Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer\u2019s disease. Lancet 2(8000):1403. https:\/\/doi.org\/10.1016\/s0140-6736(76)91936-x","journal-title":"Lancet"},{"issue":"2","key":"2107_CR6","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.410100203","volume":"10","author":"PJ Whitehouse","year":"1981","unstructured":"Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10(2):122\u2013126. https:\/\/doi.org\/10.1002\/ana.410100203","journal-title":"Ann Neurol"},{"issue":"4589","key":"2107_CR7","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, DeLong MR (1983) Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation. Science 219(4589):1184\u20131190. https:\/\/doi.org\/10.1126\/science.6338589","journal-title":"Science"},{"issue":"4558","key":"2107_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL III, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217(4558):408\u201314","journal-title":"Science"},{"key":"2107_CR9","volume-title":"The biology of cholinesterases","author":"A Silver","year":"1974","unstructured":"Silver A (1974) The biology of cholinesterases. Elsevier, Amsterdam"},{"issue":"4","key":"2107_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2990.1978.tb00545.x","volume":"4","author":"EK Perry","year":"1978","unstructured":"Perry EK, Perry RH, Blessed G, Tomlinson BE (1978) Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 4(4):273\u2013277. https:\/\/doi.org\/10.1111\/j.1365-2990.1978.tb00545.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"2107_CR11","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2174\/156720510791383868","volume":"7","author":"S Darvesh","year":"2010","unstructured":"Darvesh S, Reid GA, Martin E (2010) Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues. Curr Alzheimer Res 7(5):386\u2013400. https:\/\/doi.org\/10.2174\/156720510791383868","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"2107_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0006-8993(89)90419-8","volume":"498","author":"C Geula","year":"1989","unstructured":"Geula C, Mesulam M (1989) Special properties of cholinesterases in the cerebral cortex of Alzheimer\u2019s disease. Brain Res 498(1):185\u2013189. https:\/\/doi.org\/10.1016\/0006-8993(89)90419-8","journal-title":"Brain Res"},{"issue":"Suppl 2","key":"2107_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/00002093-199501002-00005","volume":"9","author":"C Geula","year":"1995","unstructured":"Geula C, Mesulam MM (1995) Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis Assoc Disord 9(Suppl 2):23\u201328. https:\/\/doi.org\/10.1097\/00002093-199501002-00005","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"2107_CR14","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/ana.410220603","volume":"22","author":"MM Mesulam","year":"1987","unstructured":"Mesulam MM, Geula C, Mor\u00e1n MA (1987) Anatomy of cholinesterase inhibition in Alzheimer\u2019s disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann Neurol 22(6):683\u2013691. https:\/\/doi.org\/10.1002\/ana.410220603","journal-title":"Ann Neurol"},{"issue":"6","key":"2107_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2174\/1567205018666210827122704","volume":"18","author":"GA Reid","year":"2021","unstructured":"Reid GA, Darvesh S (2021) Interaction of exogenous butyrylcholinesterase with \u03b2-amyloid plaques in 5XFAD\/butyrylcholinesterase-knockout mouse brain. Curr Alzheimer Res 18(6):470\u2013481. https:\/\/doi.org\/10.2174\/1567205018666210827122704","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"2107_CR16","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/ana.410420613","volume":"42","author":"AL Guillozet","year":"1997","unstructured":"Guillozet AL, Smiley JF, Mash DC, Mesulam MM (1997) Butyrylcholinesterase in the life cycle of amyloid plaques. Ann Neurol 42(6):909\u2013918. https:\/\/doi.org\/10.1002\/ana.410420613","journal-title":"Ann Neurol"},{"issue":"10","key":"2107_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2174\/1567205013666160404120542","volume":"13","author":"S Darvesh","year":"2016","unstructured":"Darvesh S (2016) Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer\u2019s disease. Curr Alzheimer Res 13(10):1173\u20131177. https:\/\/doi.org\/10.2174\/1567205013666160404120542","journal-title":"Curr Alzheimer Res"},{"issue":"2","key":"2107_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/JAD-170164","volume":"58","author":"IR Macdonald","year":"2017","unstructured":"Macdonald IR, Maxwell SP, Reid GA et al (2017) Quantification of butyrylcholinesterase activity as a sensitive and specific biomarker of Alzheimer\u2019s disease. J Alzheimers Dis 58(2):491\u2013505. https:\/\/doi.org\/10.3233\/JAD-170164","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"2107_CR19","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.410360506","volume":"36","author":"MM Mesulam","year":"1994","unstructured":"Mesulam MM, Geula C (1994) Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol 36(5):722\u2013727. https:\/\/doi.org\/10.1002\/ana.410360506","journal-title":"Ann Neurol"},{"key":"2107_CR20","doi-asserted-by":"publisher","unstructured":"Shinotoh H, Hirano S, Shimada H (2021) PET imaging of acetylcholinesterase. In: Dierckx RA, Otte A, de Vries EF, van Waarde A, Lammertsma AA (eds) PET and SPECT of neurobiological systems. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-030-53176-8_7","DOI":"10.1007\/978-3-030-53176-8_7"},{"issue":"12","key":"2107_CR21","first-page":"2032","volume":"45","author":"A Roivainen","year":"2004","unstructured":"Roivainen A, Rinne J, Virta J et al (2004) Biodistribution and blood metabolism of 1\u201311C-methyl-4-piperidinyl n-butyrate in humans: an imaging agent for in vivo assessment of butyrylcholinesterase activity with PET. J Nucl Med 45(12):2032\u20132039","journal-title":"J Nucl Med"},{"issue":"1","key":"2107_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.20672","volume":"59","author":"DE Kuhl","year":"2006","unstructured":"Kuhl DE, Koeppe RA, Snyder SE et al (2006) In vivo butyrylcholinesterase activity is not increased in Alzheimer\u2019s disease synapses. Ann Neurol 59(1):13\u201320. https:\/\/doi.org\/10.1002\/ana.20672","journal-title":"Ann Neurol"},{"issue":"2","key":"2107_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.trci.2017.01.005","volume":"3","author":"DR DeBay","year":"2017","unstructured":"DeBay DR, Reid GA, Pottie IR et al (2017) Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer\u2019s disease. Alzheimers Dement 3(2):166\u2013176. https:\/\/doi.org\/10.1016\/j.trci.2017.01.005","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2107_CR24","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0969-8051(96)00033-9","volume":"23","author":"G Bormans","year":"1996","unstructured":"Bormans G, Sherman P, Snyder SE, Kilbourn MR (1996) Synthesis of carbon-11- and fluorine-18-labeled 1-methyl-4-piperidyl-4\u2019-fluorobenzoate and their biodistribution in mice. Nucl Med Biol 23(4):513\u2013517. https:\/\/doi.org\/10.1016\/0969-8051(96)00033-9","journal-title":"Nucl Med Biol"},{"issue":"1","key":"2107_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2225797","volume":"38","author":"S Darvesh","year":"2023","unstructured":"Darvesh S, Banfield S, Dufour M et al (2023) A method for the efficient evaluation of substrate-based cholinesterase imaging probes for Alzheimer\u2019s disease. J Enzyme Inhib Med Chem 38(1):2225797. https:\/\/doi.org\/10.1080\/14756366.2023.2225797","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"40","key":"2107_CR26","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S et al (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci 26(40):10129\u201310140. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-06.2006","journal-title":"J Neurosci"},{"key":"2107_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","volume":"298","author":"GA Reid","year":"2015","unstructured":"Reid GA, Darvesh S (2015) Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model. Neuroscience 298:424\u2013435. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.04.039","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"2107_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1385\/JMN:30:1:193","volume":"30","author":"B Li","year":"2006","unstructured":"Li B, Duysen EG, Saunders TL, Lockridge O (2006) Production of the butyrylcholinesterase knockout mouse. J Mol Neurosci 30(1\u20132):193\u2013195. https:\/\/doi.org\/10.1385\/JMN:30:1:193","journal-title":"J Mol Neurosci"},{"issue":"9","key":"2107_CR29","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1113\/EP088870","volume":"105","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert N, Hurst V, Ahluwalia A (2020) The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. Exp Physiol 105(9):1459\u20131466. https:\/\/doi.org\/10.1113\/EP088870","journal-title":"Exp Physiol"},{"issue":"4","key":"2107_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.neuroscience.2005.07.014","volume":"135","author":"Y Ma","year":"2005","unstructured":"Ma Y, Hof PR, Grant SC et al (2005) A three-dimensional digital atlas database of the adult C57BL\/6J mouse brain by magnetic resonance microscopy. Neuroscience 135(4):1203\u20131215. https:\/\/doi.org\/10.1016\/j.neuroscience.2005.07.014","journal-title":"Neuroscience"},{"issue":"10","key":"2107_CR31","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1523\/JNEUROSCI.4456-03.2004","volume":"24","author":"N Okamura","year":"2004","unstructured":"Okamura N, Suemoto T, Shimadzu H et al (2004) Styrylbenzoxazole derivatives for in vivo imaging of amyloid plaques in the brain. J Neurosci 24(10):2535\u20132541. https:\/\/doi.org\/10.1523\/JNEUROSCI.4456-03.2004","journal-title":"J Neurosci"},{"key":"2107_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuroscience.2012.12.054","volume":"234","author":"GA Reid","year":"2013","unstructured":"Reid GA, Chilukuri N, Darvesh S (2013) Butyrylcholinesterase and the cholinergic system. Neuroscience 234:53\u201368. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.12.054","journal-title":"Neuroscience"},{"issue":"1","key":"2107_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","volume":"71","author":"S Darvesh","year":"2012","unstructured":"Darvesh S, Cash MK, Reid GA et al (2012) Butyrylcholinesterase is associated with \u03b2-amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of Alzheimer disease. J Neuropathol Exp Neurol 71(1):2\u201314. https:\/\/doi.org\/10.1097\/NEN.0b013e31823cc7a6","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"2107_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/BF02815095","volume":"30","author":"P G\u00f3mez-Ramos","year":"1997","unstructured":"G\u00f3mez-Ramos P, Mor\u00e1n MA (1997) Ultrastructural localization of butyrylcholinesterase in senile plaques in the brains of aged and Alzheimer disease patients. Mol Chem Neuropathol 30(3):161\u2013173. https:\/\/doi.org\/10.1007\/BF02815095","journal-title":"Mol Chem Neuropathol"},{"issue":"13","key":"2107_CR35","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.7150\/thno.54589","volume":"11","author":"L Rejc","year":"2021","unstructured":"Rejc L, G\u00f3mez-Vallejo V, Joya A et al (2021) Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease. Theranostics 11(13):6542\u20136559. https:\/\/doi.org\/10.7150\/thno.54589","journal-title":"Theranostics"},{"issue":"Supp 2","key":"2107_CR36","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1002\/alz.14338","volume":"66","author":"GD Rabinovici","year":"2025","unstructured":"Rabinovici GD, Knopman DS, Arbizu J et al (2025) Updated appropriate use criteria for amyloid and tau PET: a report from the Alzheimer\u2019s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup. J Nucl Med 66(Supp 2):S5. https:\/\/doi.org\/10.1002\/alz.14338","journal-title":"J Nucl Med"},{"issue":"3","key":"2107_CR37","doi-asserted-by":"publisher","first-page":"822","DOI":"10.18632\/aging.206227","volume":"17","author":"S Darvesh","year":"2025","unstructured":"Darvesh S, Cash MK, Forrestall K et al (2025) Differential senolytic inhibition of normal versus A\u03b2-associated cholinesterases: implications in aging and Alzheimer\u2019s disease. Aging 17(3):822\u2013850. https:\/\/doi.org\/10.18632\/aging.206227","journal-title":"Aging"},{"issue":"1","key":"2107_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-016-0110-7","volume":"16","author":"H Wang","year":"2016","unstructured":"Wang H, Tang G, Hu K (2016) Comparison of three 18F-labeled carboxylic acids with 18F-FDG of the differentiation tumor from inflammation in model mice. BMC Med Imaging 16(1):2. https:\/\/doi.org\/10.1186\/s12880-016-0110-7","journal-title":"BMC Med Imaging"},{"issue":"3","key":"2107_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/BF00496619","volume":"78","author":"S Tsuji","year":"1983","unstructured":"Tsuji S, Larabi Y (1983) A modification of thiocholine-ferricyanide method of Karnovsky and Roots for localization of acetylcholinesterase activity without interference by Koelle\u2019s copper thiocholine iodide precipitate. Histochemistry 78(3):317\u2013323. https:\/\/doi.org\/10.1007\/BF00496619","journal-title":"Histochemistry"},{"issue":"1","key":"2107_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005593","volume":"2006","author":"J Birks","year":"2006","unstructured":"Birks J (2006) Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev 2006(1):CD005593. https:\/\/doi.org\/10.1002\/14651858.CD005593","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-026-02107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-026-02107-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-026-02107-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:17:35Z","timestamp":1779981455000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-026-02107-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":40,"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1007\/s11307-026-02107-7","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving animals were approved by the Dalhousie University Animal Care Committee (24\u2013037). Mice were cared for in accordance with Canadian Council on Animal Care guidelines. This article does not contain any studies with human participants. Animal handling and experimental procedures followed ARRIVE 2.0 guidelines [\n                      \n                      ].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Sultan Darvesh is a scientific co-founder and stockholder in Treventis Corporation. Sultan Darvesh, Ian R. Pottie and Ian R. Macdonald are listed as co-inventors on patents assigned to Treventis Corporation. No other authors have financial disclosures or conflicts of interest with this submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}